Business Development & Partnership

Home > Business Development & Partnership

Hanmi Pharm. is dedicated to develop and provide innovative, valuable drugs to its customers. In order to pursue this goal, Hanmi is highly interested in collaborative opportunities including product in and out-licensing, co-research, co-development, co-promotion, and co-marketing with research institutes, pharmaceutical companies, and biotech companies domestically and internationally.

Finished product

Hanmi Fine Chemical's Logo
  • Foundation in Feb. 1984
  • KGMP certification by KFDA in 1999
  • US FDA inspection, ANDA approved in 2008
  • EU GMP certification by MHRA in 2000, 2006, and 2008, BUG in 2003, and BSG in 2007
  • US FDA inspection in April 2011

GMP Certificates

Hanmi Fine Chemical (2 API Plants)

Cephalosporin API Plant

  • Ceftriaxone sodium
  • Cefotaxime sodium
  • Ceftazidime for Injection
  • Cefotiam HCl
  • Ceftizoxime sodium
  • Cefixime
  • Cefpodoxime

General API Plant

  • Clopidogrel
  • Esomeprazole
  • Orlistat
  • Montelukast
  • Pregabalin
  • Voriconazole
  • Entecavir

- Providing customized service from development to multi-ton scale production

- Approved by UK MHRA, German BUG, US FDA and Australian TGA